NCT00931827View on ClinicalTrials.gov

Acceptability of Long-term Progestin-only Contraception in Europe

CompletedOBSERVATIONAL
Enrollment

436

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Contraception
Interventions
DRUG

Levonorgestrel IUS (Mirena, BAY86-5028)

Patients under daily life treatment receiving Mirena according to local drug information.

DRUG

Implanon (Etonogestrel)

Patients under daily life treatment receiving Implanon according to local drug information.

Trial Locations (4)

Unknown

Many Locations

Many Locations

Many Locations

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY